InfuSystem Holdings, Inc. (INFU) Income Statement

NYSE American: INFURevenue, profits, margins and EPS over 10 years.

INFU 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue+6.4%
$143.4M
2025 · hover or tap a bar for each year
2016: $70.5M (−2.3%)2017: $71.1M (+0.8%)2018: $67.1M (−5.5%)2019: $81.1M (+20.8%)2020: $97.4M (+20.1%)2021: $102.4M (+5.1%)2022: $109.9M (+7.4%)2023: $125.8M (+14.4%)2024: $134.9M (+7.2%)2025: $143.4M (+6.4%)
20162025
Gross profit+14.1%
$80.3M
2025 · hover or tap a bar for each year
2016: $44.7M (−12.6%)2017: $43.4M (−3.1%)2018: $39.0M (−10.0%)2019: $46.9M (+20.2%)2020: $58.8M (+25.3%)2021: $58.5M (−0.4%)2022: $60.6M (+3.5%)2023: $63.1M (+4.2%)2024: $70.4M (+11.6%)2025: $80.3M (+14.1%)
20162025
Operating income+73.0%
$11.9M
2025 · hover or tap a bar for each year
2016: $974,000 (−89.0%)2017: −$3.8M (−491.4%)2018: $415,0002019: $3.5M (+749.4%)2020: $8.8M (+150.4%)2021: $2.8M (−68.1%)2022: $1.7M (−41.3%)2023: $4.1M (+147.2%)2024: $6.9M (+68.6%)2025: $11.9M (+73.0%)
20162025
Net income+182.6%
$6.6M
2025 · hover or tap a bar for each year
2016: −$222,000 (−105.9%)2017: −$20.7M2018: −$1.1M2019: $1.4M2020: $17.3M (+1,173.5%)2021: $1.4M (−91.8%)2022: $18,000 (−98.7%)2023: $872,000 (+4,744.4%)2024: $2.3M (+168.9%)2025: $6.6M (+182.6%)
20162025
EPS (diluted)+177.8%
$0.50
2025 · hover or tap a bar for each year
2016: −$0.01 (−104.3%)2017: −$0.172018: −$0.052019: $0.062020: $0.81 (+1,250.0%)2021: $0.08 (−90.1%)2022: $0.01 (−87.5%)2023: $0.09 (+800.0%)2024: $0.18 (+100.0%)2025: $0.50 (+177.8%)
20162025
Net profit margin+2.9 pts
4.6%
2025 · hover or tap a point for each year
2016: −0.3% (−5.5 pts)2017: −29.1% (−28.8 pts)2018: −1.6% (+27.5 pts)2019: 1.7% (+3.3 pts)2020: 17.8% (+16.1 pts)2021: 1.4% (−16.4 pts)2022: 0.0% (−1.4 pts)2023: 0.7% (+0.7 pts)2024: 1.7% (+1.0 pts)2025: 4.6% (+2.9 pts)
20162025

INFU revenue and net income

RevenueNet incomeNet margin (right axis)

Where INFU's revenue goes

2025
Revenue
$143.4M100.0%
Cost of revenue
−$63.1M−44.0%
Gross profit
$80.3M56.0%
Sales, general & admin
−$67.5M−47.0%
Other operating expenses
−$920,000−0.6%
Operating income
$11.9M8.3%
Interest & other expense
−$1.3M−0.9%
Income taxes
−$4.0M−2.8%
Net income
$6.6M4.6%

Each bar shows an amount and its share of revenue. INFU kept 4.6% of revenue as net income.

INFU profit margins

GrossOperatingNet

INFU growth rates

to 2025
1 year3 years5 years10 years
Revenue+6.4%+9.3%+8.1%+7.1%
Gross profit+14.1%+9.9%+6.4%+4.6%
Operating income+73.0%+93.2%+6.2%+3.0%
Net income+182.6%+616.7%−17.5%+5.9%
EPS (diluted)+177.8%+268.4%−9.2%+8.1%

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

INFU quarterly EPS vs estimates

Reported EPSAnalyst estimate

InfuSystem beat the analyst EPS estimate in 8 of the last 8 quarters. Next report: November 3, 2026 (estimate $0.12).

INFU income statement

InfuSystem Holdings, Inc. annual income statement
2025202420232022202120202019201820172016
Revenue$143.4M$134.9M$125.8M$109.9M$102.4M$97.4M$81.1M$67.1M$71.1M$70.5M
Cost of revenue$63.1M$64.5M$62.7M$49.4M$43.8M$38.6M$34.2M$28.1M$27.7M$25.8M
Gross profit$80.3M$70.4M$63.1M$60.6M$58.5M$58.8M$46.9M$39.0M$43.4M$44.7M
Research & development———————$0$0$0
Sales, general & admin$67.5M$62.5M$58.0M$56.4M$51.5M$44.9M$38.9M$34.0M$35.0M$34.3M
Total operating expenses$68.4M$63.5M$59.0M$58.9M$55.7M$49.9M$43.4M$38.6M$46.2M$43.8M
Operating income$11.9M$6.9M$4.1M$1.7M$2.8M$8.8M$3.5M$415,000−$3.8M$974,000
Interest income——————$1.9M$1.4M$1.3M$1.3M
Interest expense$1.3M$1.8M$2.2M$1.4M$1.4M$1.3M$1.9M$1.4M$1.3M$1.3M
Income before taxes$10.6M$5.1M$1.9M$130,000$1.3M$7.5M$1.5M−$1.0M−$5.3M−$364,000
Income taxes$4.0M$2.7M$979,000$112,000−$163,000−$9.8M$163,000$53,000$15.4M−$142,000
Net income$6.6M$2.3M$872,000$18,000$1.4M$17.3M$1.4M−$1.1M−$20.7M−$222,000
EBITDA$25.2M$20.0M$16.5M$14.9M$17.3M$22.8M$15.8M$11.7M$8.6M$11.7M
EPS (diluted)$0.50$0.18$0.09$0.01$0.08$0.81$0.06−$0.05−$0.17−$0.01
Gross margin56.0%52.2%50.2%55.1%57.2%60.3%57.8%58.1%61.0%63.5%
Operating margin8.3%5.1%3.2%1.5%2.8%9.1%4.3%0.6%−5.4%1.4%
Net margin4.6%1.7%0.7%0.0%1.4%17.8%1.7%−1.6%−29.1%−0.3%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in INFU's financial statements (latest annual report filed February 27, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

INFU financial results

In fiscal year 2025 (ended December 31, 2025), InfuSystem reported revenue of $143.4 million, up 6.4% from the year before. It had net income of $6.6 million (up 182.6%), a net profit margin of 4.6%. Diluted earnings per share came to $0.50. Over five years revenue grew at an average rate of 8.1% a year.

See the INFU stock overview for the latest quote and news, or the INFU chart for price history and technical indicators.

INFU income statement FAQ

What is InfuSystem's annual revenue?

InfuSystem reported total revenue of $143.4 million for fiscal year 2025, which ended on December 31, 2025. That was up 6.4% from $134.9 million the previous year.

Is InfuSystem profitable?

Yes. InfuSystem reported net income of $6.6 million in fiscal 2025, a net profit margin of 4.6%; its operating margin was 8.3%.

What is InfuSystem's gross margin?

InfuSystem's gross margin was 56.0% in fiscal 2025: for every $100 of revenue, InfuSystem kept $56 after the direct cost of its products and services.

How fast is InfuSystem growing?

Revenue grew 8.1% a year on average over the last five fiscal years, from $97.4 million to $143.4 million.

What are InfuSystem's earnings per share?

InfuSystem earned $0.50 per diluted share in fiscal 2025, compared with $0.18 a year earlier.

When will InfuSystem report its next earnings?

InfuSystem is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 before the market opens.

When does InfuSystem's fiscal year end?

InfuSystem's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 27, 2026.

Medical Devices income statements